Recovery of acanthosis nigricans under prolonged metformin treatment in an adolescent with normal weight

Journal of Endocrinological Investigation

Volumn 32, Issue 11, 2009, Pages 939-940

  Wasniewska, M ^a   Arrigo, T ^a   Crisafulli, G ^a   Lombardo, F ^a   Messina, M F ^a   Salzano, G ^a   Valenzise, M ^a   De Luca, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN;

ABSENCE OF SIDE EFFECTS; ACANTHOSIS NIGRICANS; ADULT; BODY MASS; CASE REPORT; DRUG DOSE REDUCTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; HYPERKERATOSIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; MALE; ORAL GLUCOSE TOLERANCE TEST; PAPILLOMATOSIS; SKIN BIOPSY;

ACANTHOSIS NIGRICANS; ADOLESCENT; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METFORMIN; YOUNG ADULT;

EID: 77649215598     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03345776     Document Type: Letter

References (6)

1. Adigun CG, Pandya AG. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. J Eur Acad Dermatol Venereol 2009, 23: 486-7.
2. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996, 19: 1138-41.
3. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22: 1462-70.
4. Hermanns-Lê T, Hermanns JF, Piérard GE. Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol 2002, 19: 12-4.
5. Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol 2007, 57: 502-8.
6. Uyttendaele H, Koss T, Bagheri B, et al. Generalized acanthosis nigricans in an otherwise healthy young child. Pediatr Dermatol 2003, 20: 254-6.